CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 122 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q1 2023. The put-call ratio across all filers is 1.34 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $11 | -72.5% | 1,470 | -70.6% | 0.00% | -75.0% |
| Q1 2023 | $40 | +700.0% | 5,000 | +51.5% | 0.00% | – |
| Q4 2022 | $5 | -100.0% | 3,300 | +6.5% | 0.00% | -100.0% |
| Q3 2022 | $30,000 | -73.2% | 3,100 | -27.1% | 0.00% | -75.0% |
| Q2 2022 | $112,000 | +138.3% | 4,253 | -79.7% | 0.01% | +300.0% |
| Q1 2022 | $47,000 | +17.5% | 20,900 | +147.6% | 0.00% | 0.0% |
| Q4 2021 | $40,000 | -43.7% | 8,441 | -42.6% | 0.00% | 0.0% |
| Q3 2021 | $71,000 | -30.4% | 14,700 | -58.3% | 0.00% | -50.0% |
| Q2 2021 | $102,000 | – | 35,243 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BAIN CAPITAL INVESTORS LLC | 60,632,356 | $1,965,701,000 | 23.51% |
| Affinity Asset Advisors, LLC | 225,000 | $7,295,000 | 2.65% |
| Perceptive Advisors | 10,173,454 | $329,822,000 | 2.54% |
| Artal Group S.A. | 1,500,000 | $48,630,000 | 1.32% |
| Rock Springs Capital Management LP | 1,648,435 | $53,442,000 | 1.24% |
| RTW INVESTMENTS, LP | 666,666 | $21,613,000 | 0.32% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 8,900 | $289,000 | 0.28% |
| EAM Investors, LLC | 39,907 | $1,294,000 | 0.21% |
| FEDERATED HERMES, INC. | 3,113,333 | $100,934,000 | 0.19% |
| Alkeon Capital Management | 1,909,035 | $61,891,000 | 0.12% |